Filing Details
- Accession Number:
- 0001237899-12-000082
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-16 17:03:04
- Reporting Period:
- 2012-11-16
- Filing Date:
- 2012-11-16
- Accepted Time:
- 2012-11-16 17:03:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1411984 | P Daniel Plew Van | 777 Old Saw Mill River Road Tarrytown NY 10591 | Svp & General Mgr Industrial O | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-11-16 | 657 | $153.48 | 22,868 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-11-16 | 4,400 | $154.77 | 18,468 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-11-16 | 6,900 | $155.18 | 11,568 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-11-16 | 2,000 | $156.17 | 9,568 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-11-16 | 400 | $156.94 | 9,168 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-11-16 | 4,384 | $157.44 | 4,784 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,305 | Indirect | By 401(k) Plan |
Footnotes
- Represents volume-weighted average price of sales of 657 shares of Company stock on November 16, 2012 at prices ranging from $153.10 to $153.67. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2012 at each separate price.
- Represents volume-weighted average price of sales of 4,400 shares of Company stock on November 16, 2012 at prices ranging from $154.42 to $154.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2012 at each separate price.
- Represents volume-weighted average price of sales of 6,900 shares of Company stock on November 16, 2012 at prices ranging from $155.00 to $155.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2012 at each separate price.
- Represents volume-weighted average price of sales of 2,000 shares of Company stock on November 16, 2012 at prices ranging from $156.03 to $156.35. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2012 at each separate price.
- Represents volume-weighted average price of sales of 400 shares of Company stock on November 16, 2012 at prices ranging from $156.90 to $156.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2012 at each separate price.
- Represents volume-weighted average price of sales of 4,384 shares of Company stock on November 16, 2012 at prices ranging from $157.01 to $157.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2012 at each separate price.